CALC CalciMedica, Inc.
Company Analysis
Latest News
🔴 CalciMedica is trading 5.58% down today
CalciMedica is trading 5.58% down at $0.61, with no clearly reported company-specific announcement explaining the August 19, 2026 move. - The company’s annual...
🟢 CalciMedica is trading 5% up in after-hours trading; no new company-specific announcement directly explaining the move
CalciMedica is trading 5.17% up now at $0.71 after closing at $0.68 on August 14, 2026; no new company-specific announcement directly explaining the...
CalciMedica Rallies 11% on FDA Nod and Cash Lifeline, but Can a Sub-Dollar Stock Deliver on Its Pancreatitis Bet?
Shares of CalciMedica surged to $0.69, up 11% from the prior close, as investors digested a pair of catalysts: the FDA's agreement on a clearer path for the...
🟢 CalciMedica is trading 11% up today as FDA aligns on Auxora trial endpoint
CalciMedica is trading 11% up at $0.69 as investors focus on FDA alignment for Auxora’s Phase 2b acute-pancreatitis trial despite a wider-than-expected...
🟢 CalciMedica is trading 8.08% up today after July PPI showed no monthly growth
CalciMedica is trading at $0.67, up +8.08%, as U.S. markets rally after July PPI showed no monthly growth, below the expected 0.2% increase. - The S&P 500,...
CalciMedica misses second quarter 2026 EPS estimates as FDA aligns on pancreatitis trial design
CalciMedica reported a second quarter 2026 net loss of $0.45 per share, missing consensus estimates by $0.12. Despite the wider loss, the company achieved a...
🟢 CalciMedica is trading 5% up in pre-market
CalciMedica is trading 5.16% up at $0.69 after closing at $0.66 on August 10, 2026, with no new company-specific announcement or clear overnight catalyst...
🟢 CalciMedica is trading 5% up in after-hours trading, with no clear company-specific catalyst identified
CalciMedica is trading 5% up at $0.69 after closing at $0.66 on August 10, 2026, with no clear company-specific catalyst identified for the after-hours...
🔴 CalciMedica is trading 5.45% down today; no clear catalyst identified
CalciMedica is trading at $0.65, reflecting a -5.45% change, with no clear catalyst identified. - No new August 10, 2026 company announcement surfaced in...
CalciMedica, Inc. Q2 2026 Earnings Preview: What Analysts Expect on August 11, 2026
Consensus estimates for CalciMedica’s Q2 2026 report reflect zero revenue and a projected EPS loss of -$0.33, while the current share price of $0.75 remains...
🟢 CalciMedica is trading 8.4% up in pre-market with no clear catalyst identified
CalciMedica is trading 8.4% up in pre-market at $0.77, after rising from the August 6 close of $0.71; no new company-specific announcement or reliable report...
🔴 CalciMedica is trading 5.22% down today on a sharp pullback following recent volatility
CalciMedica is trading at $0.75 (-5.22%), pulling back from its August 4 close of $0.80 in a move consistent with recent short-term volatility and price...
🟢 CalciMedica is trading 15.7% up today despite no fresh company-specific catalyst
CalciMedica is trading at $0.92 (+15.72%) in pre-market despite no fresh company-specific catalyst, earnings release, or FDA update being identified. • The...
🟢 CalciMedica is trading 10.4% up today as stock stabilizes after FDA-related swings
CalciMedica is trading 10.4% up at $0.82 as the stock continues to stabilize following sharp FDA-related volatility over the past several sessions. • The...
🟢 CalciMedica is trading 5.6% up today as it stabilizes after FDA-driven volatility
CalciMedica is trading 5.6% up today at $0.78 as the stock stabilizes following sharp swings tied to its recent FDA-related rally and subsequent sell-off. •...
🟢 CalciMedica is trading 8.6% up today as it rebounds from a sharp sell-off following its FDA-driven rally
CalciMedica is trading at $0.81 (8.6% up) in after-hours as it partially rebounds from a sharp 25.7% drop during the August 3 regular session. • The move...
🔴 CalciMedica is trading 20% down today on profit-taking after FDA-driven rally
CalciMedica is trading at approximately $0.80 (20% down) as investors lock in gains following a sharp two-session rally tied to regulatory optimism. - The...
🔴 CalciMedica is trading 7.2% down today after pulling back from its recent FDA-driven rally
CalciMedica is trading at $0.93 (-7.22%) today as the stock pulls back from a recent rally fueled by FDA trial-alignment optimism. • The decline follows a...
🔴 CalciMedica is trading 5% down today as it pulls back from a multi-day rally following FDA trial alignment
CalciMedica is trading at $0.95 (5% down) in after-hours trading, pulling back slightly after a sharp multi-day rebound. • The recent upside was driven by FDA...
🟢 CalciMedica is trading 10.3% up today as rebound continues after FDA alignment on Phase 2b trial
CalciMedica is trading at $0.93 (up 10.3%), extending a sharp multi-day rebound that followed positive regulatory news regarding its lead clinical program. •...